UPDATES:DRUG COMPANY PAYS UP FOR VACCINE SIDE EFFECTS

A French appeals court has ordered drug giant Glaxo SmithKline (GSK) to pay US$6686 and $10,697, respectively, as compensation to two women who developed multiple sclerosis (MS) after receiving the hepatitis B vaccine, Engerix B.


The women, both nurses, were vaccinated as part of a massive government immunisation campaign in 1994, aimed especially at health workers. The campaign was halted in 1998 when it became apparent that recipients of the vaccine were developing MS like symptoms.


A first court judgement found no link between the vaccine and MS, but the appeals court found that, even in the absence of absolute scientific proof, there was evidence of risk that could not be ignored. More judgements are expected since the French campaign was stopped, 170 patients have filed lawsuits against GSK and Aventis Pasteur, the two main producers of the vaccine in France (Lancet, 2001; 357: 1598).

What Doctors Don't Tell You Written by What Doctors Don't Tell You

Get the Healthiest Newsletter!

Get a dose of Healthy delivered straight to your inbox. Each FREE issue features amazing content that will elevate your Body, Mind, and Spirit.

Your data is never shared with 3rd parties

Body+Mind+Spirit

TRANSFORM YOUR LIFE?

Try the Internet's Longest-Running Wellness Program.